EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC 4.0

Pancrelipase Improves Symptoms of Exocrine Pancreatic Insufficiency and Health-Related Quality of Life in a Real-World Population of Patients with Chronic Pancreatitis

Mohamed O Othman, Jens J Kort, Mitchell L Ramsey, Tamas A Gonda, Luis F Lara, Saad Jazrawi, Tara Keihanian, Walter Park, Neil R Brett, Diala Harb, Moming Li, Guru Trikudanathan

Digestive Diseases and Sciences · 2026-09 · 71 (9) · 4318-4328

DOI: 10.1007/s10620-026-09952-0 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Digestive Diseases and Sciences, online erschienen am 13.05.2026. Verfasst von Mohamed O Othman und 11 weiteren Autor:innen. Beteiligte Einrichtung: Baylor College of Medicine, Houston, TX, USA. mohamed.othman@bcm.edu. Hauptthemen laut MEDLINE: Exocrine Pancreatic Insufficiency, Quality of Life, Pancreatitis, Chronic, Pancrelipase. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: AbbVie.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Treatment for exocrine pancreatic insufficiency (EPI) includes pancreatic enzyme replacement therapy (PERT). Although PERT may improve symptoms, there are currently no EPI symptom measures to monitor PERT treatment. This analysis evaluated the utility of the Pancreatic Exocrine Insufficiency Questionnaire (PEI-Q) in patients with chronic pancreatitis and EPI treated with pancrelipase. METHODS: This prospective, observational study (NCT04949828) included adult patients with chronic pancreatitis and EPI who were recommended pancrelipase 72,000 lipase units per meal and 36,000 lipase units per snack by an independent physician. Outcomes included the change from baseline to 1 month and 3 months after treatment initiation in PEI-Q symptom score, PEI-Q symptom severity categories, and health-related quality of life (HRQoL) as measured by the PEI-Q impact domain score. RESULTS: The per-protocol population included 32 and 29 patients with data at 1 and 3 months after pancrelipase initiation, respectively. A significant reduction in mean PEI-Q symptom scores was observed from baseline to 1 month (- 1.0; p < 0.001) and 3 months (- 1.1; p < 0.001). Despite all patients having moderate/severe EPI symptoms at baseline, 62.5% and 62.1% of patients reported mild/no EPI symptoms after 1 and 3 months, respectively. There was also a significant reduction in mean PEI-Q impact scores from baseline to 1 month (- 1.0; p < 0.001) and 3 months (- 1.2; p < 0.001), indicating improved HRQoL. CONCLUSION: Pancrelipase improved patient-reported EPI symptoms and HRQoL based on the PEI-Q, which may be a useful tool for monitoring PERT treatment in patients with chronic pancreatitis and EPI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Exocrine Pancreatic InsufficiencyQuality of LifePancreatitis, ChronicPancrelipaseEnzyme Replacement TherapyHumansFemaleMiddle AgedProspective StudiesMaleAdultTreatment OutcomeSurveys and QuestionnairesAgedSeverity of Illness Index

Stichwörter der Autor:innen

Chronic pancreatitisExocrine pancreatic insufficiency (EPI)Pancreatic Exocrine Insufficiency Questionnaire (PEI-Q)Pancreatic enzyme replacement therapy (PERT)Pancrelipase

Substanzen

Pancrelipase

Autor:innen und Institutionen

  • Baylor College of Medicine, Houston, TX, USA. mohamed.othman@bcm.edu.
  • AbbVie Inc., North Chicago, IL, USA.
  • The Ohio State University Wexner Medical Center, Columbus, OH, USA.
  • New York University, New York, NY, USA.
  • University of Cincinnati, Cincinnati, OH, USA.
  • Oregon Health & Science University, Portland, OR, USA.

Förderung

  • AbbVie

Zitieren

APA

Othman, M. O., Kort, J. J., Ramsey, M. L., Gonda, T. A., Lara, L. F., Jazrawi, S., Keihanian, T., Park, W., Brett, N. R., Harb, D., Li, M., & Trikudanathan, G. (2026). Pancrelipase Improves Symptoms of Exocrine Pancreatic Insufficiency and Health-Related Quality of Life in a Real-World Population of Patients with Chronic Pancreatitis. Digestive Diseases and Sciences, 71(9), 4318-4328. https://doi.org/10.1007/s10620-026-09952-0

Vancouver

Othman MO, Kort JJ, Ramsey ML, Gonda TA, Lara LF, Jazrawi S, et al. Pancrelipase Improves Symptoms of Exocrine Pancreatic Insufficiency and Health-Related Quality of Life in a Real-World Population of Patients with Chronic Pancreatitis. Digestive Diseases and Sciences. 2026;71(9):4318-4328. doi:10.1007/s10620-026-09952-0

BibTeX
@article{Othman2026,
  author = {Othman, Mohamed O and Kort, Jens J and Ramsey, Mitchell L and Gonda, Tamas A and Lara, Luis F and Jazrawi, Saad and Keihanian, Tara and Park, Walter and Brett, Neil R and Harb, Diala and Li, Moming and Trikudanathan, Guru},
  title = {Pancrelipase Improves Symptoms of Exocrine Pancreatic Insufficiency and Health-Related Quality of Life in a Real-World Population of Patients with Chronic Pancreatitis},
  journal = {Digestive Diseases and Sciences},
  year = {2026},
  volume = {71},
  number = {9},
  pages = {4318--4328},
  doi = {10.1007/s10620-026-09952-0}
}
Kostenlos starten →